Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 481 AL 495

Research hotspots and trends in electrical stimulation for movement disorders: a bibliometric analysis from 2016 to 2025

Liu A, Shu Z, Wen J, Cui X, Shi Y, Geng S.

Front Aging Neurosci. 2026 Apr 23;18:1793056. doi: 10.3389/fnagi.2026.1793056. eCollection 2026.

Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease

Kofoed RH, Hvingelby VS, Pineda-Pardo JA, Blesa J, Paschen S, Tandon A, Joutsa J, Glud AN.

Mov Disord. 2026 Apr;41(4):826-842. doi: 10.1002/mds.70156. Epub 2026 Feb 3.

Performance of machine learning algorithms in diffusion tensor imaging of movement disorders: an exploratory meta-analysis

Fathollahi MA, Khani Y, Bayati H, Zaman S, Mahmoudi A, Vatani Z, Amiri H, Norouzkhani N, Idjadi FZ, Karami S, Naghizadeh M, Jalali Varnamkhasti Z, Soleimani MS, Khosravi F, Golestan AH, Asadi Anar M, Shahba M, Ghaedamini A, Arab Bafrani M.

Biomed Eng Online. 2026 Feb 7;25(1):53. doi: 10.1186/s12938-026-01528-3.

Basal ganglia cryptococcomas presenting as parkinsonism in an immunocompetent patient

Ruiz LLP, Arévalo-Carvajal PF, Agudelo LG, Mariño DA.

IDCases. 2026 May 8;44:e02592. doi: 10.1016/j.idcr.2026.e02592. eCollection 2026.

Trazodone for management of depression in Parkinson's disease: expert opinion and proposal for a treatment algorithm

Antonini A, Bentivoglio AR, Calandra-Buonaura G, Ceravolo R, Leta V, Pellecchia MT, Pilotto A, Nicoletti A.

Neurol Sci. 2026 May 14;47(6):492. doi: 10.1007/s10072-026-08978-6.

[Psychiatric Symptoms in Parkinson's Disease: Epidemiology, Pathophysiology, and Therapeutic Strategies]

Takenaka H, Baba T, Takeda A.

Brain Nerve. 2026 Jan;78(1):13-20. doi: 10.11477/mf.188160960780010013.

Comparing phenotypic features between Parkinson's disease dementia and dementia with Lewy bodies

Gunawardana CW, Burke PGR, Ignatavicius A, Matar E, Lewis SJG.

J Neurol. 2026 Feb 10;273(2):132. doi: 10.1007/s00415-026-13649-9.

[Basal ganglia and movement disorders-Part 2: … and if it is not Parkinson's disease? : Nondegenerative causes and neuroradiological patterns]

Garner M.

Radiologie (Heidelb). 2026 Apr;66(4):295-303. doi: 10.1007/s00117-026-01591-w. Epub 2026 Mar 16.

The central cholinergic system as a therapeutic target in Parkinson's disease

Miller SJ, Yue JS, Bozal SB, Logan R, Hafler BP.

J Parkinsons Dis. 2026 May;16(3):391-415. doi: 10.1177/1877718X261427270. Epub 2026 Mar 19.

Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes

Swathi M, Bedadakota SS, Animish A, Suthindhiran K, Jayasri MA.

3 Biotech. 2026 Apr;16(4):127. doi: 10.1007/s13205-025-04674-y. Epub 2026 Mar 9.

Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trials

Stefanou MI, Panagiotopoulos E, Tentolouris A, Theodorou A, Papagiannopoulou G, Athanasaki A, Tsalouchidou PE, Peppa M, Lambadiari V, Konitsiotis S, Mengel A, Paraskevas GP, Tentolouris N, Tsivgoulis G.

Ther Adv Neurol Disord. 2026 Jan 31;19:17562864251408269. doi: 10.1177/17562864251408269. eCollection 2026.

When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions

Gabriel ED, Eisinger RS, Lee JM, Hamimi S, Kim H, Howard SD, Halpern CH.

Mov Disord. 2026 Mar 4. doi: 10.1002/mds.70258. Online ahead of print.

Movement Disorders in Cabo Verde: Epidemiology, Access Barriers, and Public Health Implications in an Aging Island Population

Tolentino LC, Monteiro JFG, Brito Pires C, Fortes A.

Int J Public Health. 2026 Mar 3;71:1608728. doi: 10.3389/ijph.2026.1608728. eCollection 2026.

Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score

Okubadejo NU, Schaeffer E, Noyce AJ, Heinzel S, Burn DJ, Fung VS, Postuma RB, Berg D.

Mov Disord. 2026 May;41(5):1085-1090. doi: 10.1002/mds.70231. Epub 2026 Feb 17.

PARQ: A Complexity-Consensus Aware Automatic Assessment of Motor Disease Severity in Parkinson's Disease

Chakraborty I, Trushenski K, Khan SS, Taneff Y, Tarakad A, Anandan C, Bellows ST, Yilmaz AY, Balakrishnan G, Vanegas-Arroyave N, Sabharwal A.

Res Sq [Preprint]. 2026 Feb 9:rs.3.rs-8694861. doi: 10.21203/rs.3.rs-8694861/v1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias